Avita Medical is an international company focused on commercialising spray-on skin technology developed in Perth. Originally known as Clinical Cell Culture, it was founded in 1993 by burns specialist Dr Fiona Wood and fellow researcher Marie Stoner with funding from Telethon. It listed on the ASX in 2002 and changed its name after a merger with Visiomed Group in 2008. The company shifted its domicile to the US in 2020.
Avita Medical
Follow
Get notifications in MyBN when activity occurs.
Company Activity
NEW ROLE: Jim Corbett, Chief Executive | 13 Nov 2024 | |
NEWS: Tagged in Avita brings RECELL back to Australia | 13 Nov 2024 | |
NEWS: Tagged in Avita secures US approval | 31 May 2024 | |
NEWS: Tagged in Avita gains key US approval | 08 Jun 2023 | |
NEWS: Tagged in Board moves June 11-29 | 04 Apr 2023 | |
NEWS: Tagged in From lab to boardroom – kick-starting medtech brainwaves | 20 Sep 2022 | |
NEW ROLE: Michael Holder, | 01 Mar 2022 | |
NEW ROLE: Kathy McGee, | 01 Mar 2022 | |
NEW ROLE: Sean Ekins, | 01 Mar 2022 |